Investigation of selected cytokine genes suggests that IL2RA and the TNF/LTA locus are risk factors for severe alopecia areata

British Journal of Dermatology

Volumn 167, Issue 6, 2012, Pages 1360-1365

  Redler, S ^a   Albert, F ^a   Brockschmidt, F F ^a   Herold, C ^b   Hanneken, S ^c   Eigelshoven, S ^c   Giehl, K A ^d   Kruse, R ^e   Lutz, G ^f   Wolff, H ^d   Blaumeiser, B ^g   Bohm M ^h   Becker, T ^a,b   Nothen M M ^a   Betz, R C ^a  

^a UNIVERSITY OF BONN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e Dermatological Practice   (Germany)

^f Dermatological Practice Hair and Nail ^*  (Germany)

^g ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^h UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 23; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; AGED; ALOPECIA AREATA; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE LOCATION; GENE LOCUS; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALOPECIA AREATA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84870238418     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12004     Document Type: Article

References (43)

1. Safavi KH, Muller SA, Suman VJ, et al. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995; 70: 628-33.
2. Gilhar A, Paus R, Kalish RS,. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 2007; 117: 2019-27.
3. Tobin DJ,. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J Investig Dermatol Symp Proc 2003; 8: 176-81.
4. Peckham SJ, Sloan SB, Elston DM,. Histologic features of alopecia areata other than peribulbar lymphocytic infiltrates. J Am Acad Dermatol 2011; 65: 615-20.
5. Gilhar A, Landau M, Assy B, et al. Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice. Arch Dermatol 2002; 138: 916-22.
6. Galbraith GM, Palesch Y, Gore EA, et al. Contribution of interleukin 1beta and KM loci to alopecia areata. Hum Hered 1999; 49: 85-9.
7. Galbraith GM, Pandey JP,. Tumour necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum Genet 1995; 96: 433-6.
8. Tazi-Ahnini R, Cox A, McDonagh AJ, et al. Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction. Eur J Immunogenet 2002; 29: 25-30.
9. Tazi-Ahnini R, McDonagh AJ, Cox A, et al. Association analysis of IL1A and IL1B variants in alopecia areata. Heredity 2001; 87: 215-19.
10. Shimizu T, Hizawa N, Honda A, et al. Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata. Genes Immun 2005; 6: 285-9.
11. Tarlow JK, Clay FE, Cork MJ, et al. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 1994; 103: 387-90.
12. Cork MJ, Tarlow JK, Clay FE, et al. An allele of the interleukin-1 receptor antagonist as a genetic severity factor in alopecia areata. J Invest Dermatol 1995; 104: 15S-16S.
13. Barahmani N, de Andrade M, Slusser J, et al. Interleukin-1 receptor antagonist allele 2 and familial alopecia areata. J Invest Dermatol 2002; 118: 335-7.
14. Stahl EA, Raychaudhuri S, Remmers EF, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010; 42: 508-14.
15. Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359: 2767-77.
16. Hafler DA, Compston A, Sawcer S, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851-62.
17. Cooper JD, Smyth DJ, Smiles AM, et al. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet 2008; 40: 1399-401.
18. van Heel DA, Franke L, Hunt KA, et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007; 39: 827-9.
19. Gateva V, Sandling JK, Hom G, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009; 41: 1228-33.
20. Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat Genet 2010; 42: 703-6.
21. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40: 955-62.
22. Nair RP, Ruether A, Stuart PE, et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 2008; 128: 1653-61.
23. Lowe CE, Cooper JD, Brusko T, et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet 2007; 39: 1074-82.
24. Boraska V, Rayner NW, Groves CJ, et al. Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes. BMC Med Genet 2010; 11: 69.
25. Schena FP, Cerullo G, Torres DD, et al. Role of interferon-gamma gene polymorphisms in susceptibility to IgA nephropathy: a family-based association study. Eur J Hum Genet 2006; 14: 488-96.
26. Erlich HA, Lohman K, Mack SJ, et al. Association analysis of SNPs in the IL4R locus with type I diabetes. Genes Immun 2009; 10 (Suppl. 1): S33-41.
27. Dema B, Martinez A, Fernandez-Arquero M, et al. The IL6-174G/C polymorphism is associated with celiac disease susceptibility in girls. Hum Immunol 2009; 70: 191-4.
28. Olsen EA, Hordinsky MK, Price VH, et al. Alopecia areata investigational assessment guidelines-Part II. National Alopecia Areata Foundation. J Am Acad Dermatol 2004; 51: 440-7.
29. Armitage P,. Tests for linear trends in proportions and frequencies. Biometrics 1955; 11: 375-86.
30. Burchill MA, Yang J, Vang KB, et al. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol Lett 2007; 114: 1-8.
31. Buckner JH,. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 2010; 10: 849-59.
32. Petukhova L, Duvic M, Hordinsky M, et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010; 466: 113-17.
33. Redler S, Brockschmidt FF, Forstbauer L, et al. The TRAF1/C5 locus confers risk for familial and severe alopecia areata. Br J Dermatol 2010; 162: 866-9.
34. Betz RC, Konig K, Flaquer A, et al. The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata. Br J Dermatol 2008; 158: 389-91.
35. John KK, Brockschmidt FF, Redler S, et al. Genetic variants in CTLA4 are strongly associated with alopecia areata. J Invest Dermatol 2011; 131: 1169-72.
36. Vassalli P,. The pathophysiology of tumour necrosis factors. Annu Rev Immunol 1992; 10: 411-52.
37. Pathirana D, Ormerod AD, Saiag P, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23 (Suppl. 2): 1-70.
38. Ferran M, Calvet J, Almirall M, et al. Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-alpha blocker agents: report of five cases and review of the literature. J Eur Acad Dermatol Venereol 2011; 25: 479-84.
39. Strober BE, Siu K, Alexis AF, et al. Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study. J Am Acad Dermatol 2005; 52: 1082-4.
40. Plagnol V, Howson JM, Smyth DJ, et al. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet 2011; 7: e1002216.
41. Jin Y, Birlea SA, Fain PR, et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med 2010; 362: 1686-97.
42. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010; 42: 1118-25.
43. Cho JH, Gregersen PK,. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 2011; 365: 1612-23.